DEA

The Federal Drug Enforcement Administration "prescription series" proposal: Continuing concerns

Citation:

Gilson AM, Joranson DE. The Federal Drug Enforcement Administration "prescription series" proposal: Continuing concerns. J Pain Palliat Care Pharmacother 2007;21:21-24.

Abstract:
Author: 

Gilson AM, Joranson DE. The Federal Drug Enforcement Administration "prescription series" proposal: Continuing concerns. J Pain Palliat Care Pharmacother 2007;21:21-24.

Two leading health and pain policy analysts discuss the implications of the federal Drug Enforcement Administration proposed position on the legality of practitioners writing series of controlled substance prescriptions for the purpose of providing ongoing pain management without the necessity for unneeded patient visits to their prescribers. This issue led to a series of regulatory proposals that engendered great concern in the pain management community. The proposed positive outcome from the DEA is described.

Syndicate content